Basic Information
CARDIOACC is committed to becoming a global leader in cardiovascular interventional imaging and therapeutic technology enterprises. Relying on the profound technical accumulation of the core founding team and the relentless efforts of the R&D team, the company has made rapid progress. It now owns more than 20 core invention patents and has preliminarily completed the construction of key hardware and software product technologies such as ultrasound mainframes, ICE catheters, electromagnetic positioning, and imaging algorithms.
CARDIOACC
Guangdong,China
15~50 people
October 18, 2021
--
finance@cardioacc.com

